ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 245 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $55,101,000 | +7.3% | 2,275,000 | +3.4% | 1.01% | +15.1% |
| Q4 2021 | $51,348,000 | +40.5% | 2,200,000 | 0.0% | 0.87% | +52.3% |
| Q3 2021 | $36,542,000 | -38.6% | 2,200,000 | -9.9% | 0.57% | -44.6% |
| Q2 2021 | $59,552,000 | -7.7% | 2,441,658 | -2.3% | 1.04% | -7.0% |
| Q1 2021 | $64,500,000 | -38.1% | 2,500,000 | +28.2% | 1.11% | -37.9% |
| Q4 2020 | $104,247,000 | +1601.7% | 1,950,000 | +1244.8% | 1.80% | +767.1% |
| Q1 2020 | $6,126,000 | -80.8% | 145,000 | -83.7% | 0.21% | -84.5% |
| Q3 2019 | $31,941,000 | -9.8% | 887,500 | -33.0% | 1.33% | +8.8% |
| Q2 2019 | $35,417,000 | -0.4% | 1,325,000 | 0.0% | 1.22% | -20.4% |
| Q1 2019 | $35,576,000 | +1613.7% | 1,325,000 | +1225.0% | 1.54% | +1518.9% |
| Q3 2018 | $2,076,000 | -72.3% | 100,000 | -87.8% | 0.10% | -73.4% |
| Q1 2018 | $7,488,000 | -56.3% | 817,100 | +33.0% | 0.36% | -83.5% |
| Q2 2017 | $17,130,000 | -69.4% | 614,200 | -62.3% | 2.16% | -69.8% |
| Q1 2017 | $56,039,000 | +29.5% | 1,630,000 | -3.3% | 7.16% | -18.1% |
| Q4 2016 | $43,283,000 | +71.7% | 1,686,460 | +112.8% | 8.74% | +97.7% |
| Q3 2016 | $25,209,000 | +135.7% | 792,499 | +140.5% | 4.42% | +86.1% |
| Q2 2016 | $10,696,000 | -44.4% | 329,500 | -43.4% | 2.38% | -52.5% |
| Q3 2015 | $19,243,000 | -7.2% | 581,900 | +17.6% | 5.00% | -12.4% |
| Q2 2015 | $20,731,000 | – | 495,000 | – | 5.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 432,317 | $11,154,000 | 4.70% |
| Baker Brothers Advisors | 41,910,704 | $1,081,296,000 | 4.69% |
| Palo Alto Investors LP | 2,337,877 | $60,317,000 | 3.44% |
| Birchview Capital, LP | 177,000 | $4,567,000 | 2.71% |
| Longitude (Cayman) Ltd. | 188,000 | $4,850,000 | 1.86% |
| GREAT POINT PARTNERS LLC | 311,217 | $8,029,000 | 1.66% |
| Avoro Capital Advisors LLC | 2,500,000 | $64,500,000 | 1.11% |
| PFM Health Sciences, LP | 1,302,129 | $33,595,000 | 1.03% |
| HealthCor Management, L.P. | 900,490 | $23,233,000 | 0.82% |
| Eversept Partners, LP | 420,000 | $10,836,000 | 0.82% |